Report cover image

Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025

Publisher Frost & Sullivan
Published Nov 16, 2022
Length 62 Pages
SKU # MC17510002

Description

Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits
that can rapidly rule MI in or out. Both factors serve as significant drivers of the cTn diagnostics market.

Hospitals and clinical laboratories adopt high-sensitivity (hs) assays because of their ability to detect troponin in lower concentrations. The point-of-care testing (POCT) of cTn grows rapidly due to its rising applications in EDs and remote locations. POCT can provide rapid results in a shorter period than lab-based tests. In addition, companies such as QuidelOrtho and Siemens Healthineers have developed high-sensitivity POCT cTn assays that provide accurate results within a few minutes.

In this report, Frost & Sullivan overviews the cTn diagnostics market and includes troponin I and troponin T. Our testing locations are independent laboratories, physicians’ offices, urgent care and nursing facilities, inpatient hospitals, and emergency rooms. The study covers sensitive and
hs-cTn tests.

The report also includes the following:
• Market size by revenue, covering historic and forecast data by segment (lab-based tests and POCT) and region (North America, Europe,
Asia-Pacific, and the rest of the world)
• Challenges and drivers
• Competitive landscape, including company market share for lab-based tests and POCT
• Future trends and growth opportunities for stakeholders

North America is the leading region in the cTn diagnostics market, with hospitals and laboratories shifting toward high-sensitivity assays following approval from the United States Food and Drug Administration in 2017. Frost & Sullivan’s research shows high consolidation in the cTn diagnostics market, with players such as Abbot, Roche, and Siemens Healthineers dominating. New players are entering this market, especially in the POCT segment.

Table of Contents

62 Pages
    • Why is it Increasingly Difficult to Grow?
    • The Strategic Imperative 8
    • The Impact of the Top 3 Strategic Imperatives on the Cardiac Troponin (cTn) Diagnostics Industry
    • Growth Opportunities Fuel the Growth Pipeline Engine
    • Cardiac Biomarkers
    • Timeline for Cardiac Biomarkers for MI
    • cTns
    • Clinical Pathway for MI Diagnosis
    • cTn Diagnostics
    • Scope of Analysis
    • Segmentation
    • Competitors
    • Growth Metrics
    • Growth Drivers
    • Growth Restraints
    • Forecast Assumptions
    • Revenue Forecast
    • Revenue Forecast by Product Type
    • Revenue Forecast by Region
    • Revenue Forecast Analysis
    • Revenue Forecast Analysis by Region
    • Competitive Environment
    • Revenue Share
    • Revenue Share Analysis
    • Company Mapping
    • Companies to Watch
    • High-sensitivity Troponin Diagnostic-Emerging Applications
    • New Biomarkers for MI
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast by Region
    • Forecast Analysis
    • Growth Metrics
    • Revenue Forecast by Product Type
    • Revenue Forecast by Region
    • Forecast Analysis
    • Growth Opportunity 1: Rapid Diagnostics for EDs
    • Growth Opportunity 2: hs-cTn POCT
    • Growth Opportunity 3: Digital Health and Diagnostics Interconvergence Model
    • Growth Opportunity 4: Specific and Sensitive Assays for Rapid MI Detection
    • Your Next Steps
    • Why Frost, Why Now?

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us